Sanos Group
Christoffer von Sehested is a highly experienced professional in the pharmaceutical industry, currently serving as the Chief Executive Officer at Studies&Me and Chief Innovation Officer at Sanos Group A/S. With a background in clinical operations and project management, Christoffer has a proven track record of delivering successful projects and solutions to clients. Christoffer has held various leadership roles at reputable companies such as NBCD A/S, KLIFO A/S, Veloxis Pharmaceuticals, and more. Christoffer is skilled in eClinical strategy development, risk-based monitoring, protocol design, vendor management, and study management. Christoffer holds a Mini MBA for Pharma, PMP certification, and a High School degree in Chemistry, Math, Physics, and Japanese.
Sanos Group
Sanos Group is a Full Circle Clinical Research & Development Organization encompassing five independent business units: NBCD, Sanos Clinic, Sanos Supply, Studies&Me and Blueskin. Every division within the Sanos Group is committed to delivering top-tier clinical research, constantly enhancing our approach to pioneering innovative clinical trials for both clients and patients.